Enveric Biosciences (ENVB) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ENVB Enveric Biosciences

Watchlist

0.3726
-0.0499-11.81%

Trading Jan 7 11:17 ET

3.79MMarket Cap-0.15P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Enveric Biosciences to Release Investor Presentation
TipRanksJan 3 16:47 ET
Express News | Enveric Biosciences Announces New U.S. Patents Supporting Evm301 Series and Evm201 Series Compounds
ReutersDec 2, 2024 08:00 ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
BenzingaNov 27, 2024 16:05 ET
Enveric Biosciences Completes PK EB-003 Studies
TipRanksNov 25, 2024 09:05 ET
Express News | Enveric Biosciences : Plans to Submit Eb-003 Ind Application to FDA in H2 of 2025
ReutersNov 25, 2024 09:02 ET
Express News | Enveric Biosciences Preclinical Pharmacokinetic Studies of Eb-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-Like Behavior
ReutersNov 25, 2024 09:01 ET

Comments

Jaguar8

Jan 6 07:36

NEWS

$Enveric Biosciences (ENVB.US)$
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2025"
Monday, 6th January at 8:30 am
Management to meet with investors and potential partners during Biotech Showcase 2025
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the trea...

Jaguar8

Dec 2, 2024 07:01

NEWS

$Enveric Biosciences (ENVB.US)$
Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds
New patents provide additional composition of matter and methods of use claims for Enveric’s EVM301 series neuroplastogenic molecules, and recently out-licensed tryptamine-derived prodrugs, including EB-002, a new chemical entity psilocin prodrug

Jaguar8

Nov 25, 2024 08:04

NEWS

$Enveric Biosciences (ENVB.US)$
Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior
Dose-proportional oral bioavailability without clinical signs, including those associated with hallucinogenic compounds, was demonstrated in rat and dog pharmacokinetic (PK) studies while significant brain penetration was observed in rat
Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enver...

Trytosaveabit

Nov 25, 2024 08:03

Update

$Enveric Biosciences (ENVB.US)$ Reuters· 1 min ago
Enveric Biosciences Preclinical Pharmacokinetic Studies of Eb-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-Like Behavior

dSuu

Nov 21, 2024 07:50

$Enveric Biosciences (ENVB.US)$ whoaaaaaa

Heat List

Overall

No Data